NCT07378722 Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease
| NCT ID | NCT07378722 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rumesa Butt |
| Condition | Parkinson s Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-02-05 |
| Primary Completion | 2026-04-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-02-05 with a primary completion date of 2026-04-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parkinson's disease (PD) is a progressive neurodegenerative disorder commonly associated with gait disturbances, balance impairments, and freezing of gait, which significantly increase the risk of falls and reduce functional independence. Conventional physical therapy improves mobility in individuals with PD; however, persistent gait deficits often remain. Rhythmic Auditory Stimulation (RAS) is an emerging, evidence-based intervention that uses external auditory cues to enhance gait timing, stride length, and movement initiation. This randomized controlled trial aims to evaluate the effectiveness of rhythmic auditory stimulation using personalized music therapy combined with conventional physical therapy compared to conventional physical therapy alone in individuals with Parkinson's disease. The primary outcomes include freezing of gait, gait velocity, and balance performance. Forty-two clinically diagnosed Parkinson's disease patients will be randomly allocated into two groups. Group A will receive conventional physical therapy, while Group B will receive rhythmic auditory stimulation using personalized music in addition to conventional therapy over an 8-week intervention period. The findings of this study may provide clinical evidence supporting the integration of personalized rhythmic auditory stimulation into rehabilitation programs for improving gait and balance in individuals with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * According to the Queen Square Brain Bank standard , clinical diagnosed patients of PD Both male and females ages 45-55 The mini mental state examination scale MMSE screening without severe cognitive impairment,can cooperate with this study \> 23 Mild bergs balance scale BBS score (21-40 ) score Exclusion Criteria: * A history of neoplasms; severe cardiovascular, respiratory, visual, auditory, andmuscular-skeletal disease; other neurological conditions; and neurologic music therapy inthelast3 months. Other disorders that could potentially influence balance and walking.
Contact & Investigator
Rumesa Aslam, MSPTN
PRINCIPAL INVESTIGATOR
The University of Lahore, Lahore
Frequently Asked Questions
Who can join the NCT07378722 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 55 Years, studying Parkinson s Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07378722 currently recruiting?
Yes, NCT07378722 is actively recruiting participants. Contact the research team at rumesaaslam5@gmail.com for enrollment information.
Where is the NCT07378722 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07378722 clinical trial?
NCT07378722 is sponsored by Rumesa Butt. The principal investigator is Rumesa Aslam, MSPTN at The University of Lahore, Lahore. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.